[unable to retrieve full-text content]
Moderna on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine maker looks launch its second product in the U.S. later this year.
[unable to retrieve full-text content]
Moderna on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine maker looks launch its second product in the U.S. later this year.